MoneyWorks4Me

Bacil Pharma - Quaterly Results

13 Aug 2026 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended June 2026. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Loss for the quarter ended June 2026 is Rs. -0.16 millions as compared to Net Profit of Rs. 6.69 millions of corresponding quarter ended June 2025Operating profit for the quarter ended June 2026 decreased to 0.66 millions as compared to 8.94 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.85 0.00
Other Income 0.89 10.03 -91.13 0.89 10.03 -91.13 12.35 0.00 0.00
PBIDT 0.66 8.94 -92.62 0.66 8.94 -92.62 9.90 -0.58 -1806.90
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
PBDT 0.66 8.94 -92.62 0.66 8.94 -92.62 9.90 -0.59 -1777.97
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00
PBT 0.66 8.94 -92.62 0.66 8.94 -92.62 9.90 -0.62 -1696.77
TAX 0.82 2.25 -63.56 0.82 2.25 -63.56 -5.65 0.00 0.00
Deferred Tax 0.82 0.00 0.00 0.82 0.00 0.00 -5.65 0.00 0.00
PAT -0.16 6.69 -102.39 -0.16 6.69 -102.39 15.55 -0.62 -2608.06
Equity 139.70 139.70 0.00 139.70 139.70 0.00 139.70 139.70 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.92 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..